Related Articles
Targeting Bruton's tyrosine kinase signaling as an emerging therapeutic agent of B‑cell malignancies (Review)
Involvement of Blnk and Foxo1 in tumor suppression in BCR‑ABL1‑transformed pro‑B cells
Assessment of biochemical recurrence of prostate cancer (Review)
The tetramerization domain-independent Ras activation by BCR-ABL oncoprotein in hematopoietic cells.
Growth of chronic myeloid leukemia cells is inhibited by infection with Ad-SH2-HA adenovirus that disrupts Grb2-Bcr-Abl complexes